FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02995889

Enrollment

Registered

2016-12-19

Start date

2014-11-30

Completion date

2020-02-07

Last updated

2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer, Nonsmall Cell, Small Cell Lung Cancer

Brief summary

This study investigates the feasibility of FLT-PET to improve the diagnosis of relapse in patients with irradiated lung cancer in comparison with FDG-PET/CT.

Interventions

DEVICEFLT-PET

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* history with lung cancer, small cell or non-small cell * radiotherapy of lung cancer ended within the last 24 months * radiotherapy might be normofractionated or stereotactic * current suspicion of relapse * written and oral consent

Exclusion criteria

* communication difficulties * pregnancy or lactation

Design outcomes

Primary

Measure	Time frame
Number of patients with local and/or regional relapse	6 months

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026